期刊文献+

间接血管重建术治疗伴有认知功能障碍的脑底异常血管网病患者的疗效观察

在线阅读 下载PDF
导出
摘要 目的:探讨间接血管重建术治疗伴有认知功能障碍的脑底异常血管网病(俗称烟雾病)患者的临床疗效。方法:对36例伴有认知功能障碍的烟雾病患者进行间接血管重建术治疗。术前和术后6个月应用简易精神状态检查量表,评定认知功能状况。术后6个月复查患者脑血管造影(DSA),观察患者颅内血液循环情况。术后随访12个月,观察患者脑卒中再发情况。结果:术后6个月复查患者DSA,36例(100%)患者脑底异常血管网均较术前显著减少,并且存在新生的侧支血管;同时MMSE总分、定向力、计算力、记忆力、语言表达、图形描述和阅读理解方面评分均明显增高,治疗前后差异有统计学意义(P<0.05)。术后12个月,无一例患者出现脑出血,也无短暂性脑缺血发作及脑梗死发生。结论:间接血管重建术治疗伴有认知功能障碍的脑底异常血管网病获得良好临床疗效。
作者 赛勇
出处 《中国民康医学》 2015年第6期57-58,共2页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献8

  • 1Weinberg DG,Rahme RJ,Aoun SG,et al. Moyamoya disease:Func-tional and neurocognitive outcomes in the pediatric and adult popu-lations[J]. NeurosurgFocus,2011,30:21.
  • 2Yao Y,Han DD,Zhang T,et al. Quercetin improves cognitive defi-cits in rats with chronic cerebral ischemia and inhibits voltage de-pendent sodium channels in hippocampal CAI pyramidal neurons[J]. Phytother Res,2010,24(1):136-140.
  • 3叶玉勤,边寰,贺晓生.烟雾病的诊断和治疗进展[J].中华神经外科疾病研究杂志,2013,12(3):271-274. 被引量:11
  • 4高山.烟雾病诊断标准[J].中国卒中杂志,2008,3(7):500-501. 被引量:37
  • 5Horiuchi T,Kusano Y,Asanuma M,et al. Posterior auricular artery-middle cerebral artery bypass for additional surgery of moyamoyadisease[J]. ActaNeurochiryrgica,2012,154(3):455-456.
  • 6Kahlert P,Knipp SC,Schlamann M,et al. Silent and apparent cere-bral ischemia after percutaneous trans femoral aortic valve implan-tation a diffusion-weighted magnetic resonance imaging study[J].Circulation,2010,121(7):870-878.
  • 7吕岩松,王嵘,马国峡,卢榜良,石东付.烟雾病的代偿机制和影像学表现分析[J].中国全科医学,2013,16(21):2539-2540. 被引量:9
  • 8Pandey P,Steinberg GK. Neurosurgical advances in the treatment ofmoyamoya disease[J]. Stroke,2011,42(11):3304-3310.

二级参考文献45

  • 1高山.烟雾病诊断标准[J].中国卒中杂志,2008,3(7):500-501. 被引量:37
  • 2[1]Suzuki J,Takaku A.Cerebrovascular "moyamoya"disease.Disease showing abnormal net-like vessels in base of brain[J].Arch Neurol,1969,20:288-299.
  • 3[2]Fukui M.Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease).Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare,Japan[J].Clin Neurol Neurosurg,1997,99(suppl 2):s238-240.
  • 4[3]Ikezaki K,Han DR,Kawano T,et al.Epidemiological survey of moyamoya disease in Korea[J].Clin Neurol Neurosurg,1997,99(suppl 2):s6-10.
  • 5[4]Ikezaki K,Han DH,Kawano T,et al.A clinical comparison of definite moyamoya disease between South Korea and Japan[J].Stroke,1997,28:2513-2517.
  • 6[5]Han D,Kwon OK,Byun BJ,et al.A co-operative study:clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994).The Korean Society for Cerebrovascular Disease[J].Acta Neurochir (Wien),2000,142:1263-1273.
  • 7Khan N, Achrol AS, Guzman R, et al. Sex differences in clinical presentation and treatment outcomes in Moyamoya disease [ J ]. Neurosurgery, 2012, 71(3): 587-593.
  • 8Kleinloog R, Regli L, Rinkel GJ, et al. Regional differences in incidence and patient characteristics of moyamoya disease : a systematic review [ J ]. J Neurel Neurosurg Psychiatry, 2012, 83 (5) : 531 - 536.
  • 9Lin R, Xie Z, Zhang J, et al. Clinical and immunopathological features of Moyamoya disease [J]. PLoS One, 2012, 7(4) : e36386.
  • 10Pandey P, Steinberg GK. Neurosurgieal advances in the treatment of moyamoya disease [J]. Stroke, 2011,42(11 ): 3304-3310.

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部